Allison Cleary, MD

Allison Cleary, MD, PhD


Subspecialties: Breast pathology
Assistant Professor (Clinical), University of Utah School of Medicine


  • Breast pathology


  • Doctorate Degree—Pennsylvania State University College of Medicine
  • Medical Degree—Pennsylvania State University College of Medicine
  • Residency—Anatomic and Clinical Pathology, Brigham and Women’s Hospital
  • Fellowship—Breast Pathology, Brigham and Women’s Hospital

Current/Past Roles

  • Associate Residency Program Director, University of Utah


  • American Board of Pathology
  • United States and Canadian Academy of Pathology
  • American Society for Clinical Pathology
  • College of American Pathologists

Research Interests

  • Tumor heterogeneity
  • Inflammatory breast cancer
  • Pathology resident education


  • Penn State Alumni Achievement Award (2021)
  • John W. Kreider Award for Research and Academic Excellence (2016)
  • Moskowitz Family Endowment Award for Graduate Research Excellence (2016)
  • Grand Prize Winner, Science and SciLifeLab Prize (2015)
  • Judith S. Bond Award (2014)
  • Pennsylvania State University College of Medicine Class of 1971 Endowed Scholarship (2014)
  • Department of Defense Breast Cancer Research Program Predoctoral Traineeship Award (2010-13)

Recent Publications

Wilcock DM, et al. Quantitative imaging analysis fluorescence in situ hybridization validation for clinical HER2 testing in breast cancer. Arch Pathol Lab Med. 2023 [Published online ahead of print Mar 2023]

Cleary AS, et al. The critical role of breast specimen gross evaluation for optimal personalized cancer care. Surg Pathol Clin. 2002 Mar;15(1):121–132.

Ng J, et al. A case of recipient-derived pulmonary Kaposi sarcoma after bilateral lung transplantation. J Heart Lung Transplant. 2018;37(6):798-9.

Cleary AS, et al. Granulomatous ulcer arising in a child. Pediatr Dermatol. 2016;33(5):551-2.

Truica CI, et al. Immunotherapy in breast cancer- paving new roads? Curr Mol Pharmacol. 2016;9(3):208-16.

Cleary AS, et al. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature. 2014;508(7494):113-7.